SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-021208
Filing Date
2020-11-13
Accepted
2020-11-13 06:12:08
Documents
46
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 343824
2 ex31-1.htm EX-31.1 8788
3 ex31-2.htm EX-31.2 11412
4 ex32-1.htm EX-32.1 7289
5 ex32-2.htm EX-32.2 7129
  Complete submission text file 0001493152-20-021208.txt   2322791

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cytr-20200930.xml EX-101.INS 352434
7 XBRL SCHEMA FILE cytr-20200930.xsd EX-101.SCH 31124
8 XBRL CALCULATION FILE cytr-20200930_cal.xml EX-101.CAL 42877
9 XBRL DEFINITION FILE cytr-20200930_def.xml EX-101.DEF 99509
10 XBRL LABEL FILE cytr-20200930_lab.xml EX-101.LAB 241229
11 XBRL PRESENTATION FILE cytr-20200930_pre.xml EX-101.PRE 170186
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
CYTRX CORP (Filer) CIK: 0000799698 (see all company filings)

IRS No.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15327 | Film No.: 201309068
SIC: 2836 Biological Products, (No Diagnostic Substances)